A phase 3 study to determine the efficacy and safety of recombinant human activated protein C in severe sepsis

Update Il y a 4 ans
Reference: ISRCTN74215569

Woman and Man

Extract

Not provided at time of registration


Inclusion criteria

  • Severe sepsis


Links